Document:

Exhibit
4.3

FORM OF REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”)
is made and entered into as of       day of July, 2007
by and among Corgenix Medical Corporation, a
corporation organized and existing under the laws of the State of Nevada (the “Company”), and [Name/type
of entity] (hereinafter referred to as the “Investor”).

PRELIMINARY STATEMENT

WHEREAS, pursuant to the
Subscription Agreement of even date herewith, between the Company and the
Investor, Investor will receive common stock and warrants to purchase common
shares of the Company;

WHEREAS, the ability of the
Investors to sell their shares of common stock is subject to certain
restrictions under the Securities Act of 1933, as amended (the “1933 Act”); and

WHEREAS, the Company has agreed
to provide the Investor with a mechanism that may permit such Investor to sell
its shares of common stock in the future.

NOW, THEREFORE, in consideration
of the premises and of the mutual covenants and agreements, and subject to the
terms and conditions herein contained, the parties hereto hereby agree as
follows:

ARTICLE I

INCIDENTAL REGISTRATION RIGHTS

1.1.          Registrable Securities.  Means and includes the shares of common stock
sold pursuant to the Subscription Agreement, and those common shares underlying
the warrants issued pursuant to the Subscription Agreement.  As to any particular Registrable Securities,
such securities will cease to be Registrable Securities when (a) they have
been effectively registered under the 1933 Act and disposed of in accordance
with the registration statement covering them, (b) they are or may be
freely traded without registration pursuant to Rule 144 under the 1933 Act (or
any similar provisions that are then in effect), or (c) they have been
otherwise transferred and new certificates for them not bearing a restrictive
legend have been issued by the Company and the Company does not have “stop
transfer” instructions against them.

1.2.          Right To Include (“Piggy-Back”) Registrable
Securities.  Provided that
the Registrable Securities have not been registered, if at any time after the
date hereof but before the second anniversary of the date hereof, the Company
proposes to register any previously unregistered securities under the 1933 Act
(other than by a registration in connection with an acquisition in a manner
which would not permit registration of Registrable Securities for sale to the
public, on Form S-8, or any successor form thereto, on Form S-4, or any
successor form thereto), then the Company will give prompt written notice to
all holders of Registrable Securities of its intention to do so and of such
holders of Registrable Securities’ rights under this Section 1.2.  Upon the written request of any such holders
of Registrable Securities made within ten (10) days after the receipt of any
such notice (which request shall specify the Registrable

Securities intended to be disposed of by such holders
of Registrable Securities and the intended method of disposition thereof), the
Company will, subject to the terms of this Agreement and the Subscription
Agreement, use its commercially reasonable efforts to effect the registration
under the 1933 Act of the Registrable Securities, to the extent required to
permit the disposition (in accordance with the intended methods thereof as
aforesaid) of such Registrable Securities so to be registered, by inclusion of
such Registrable Securities in the registration statement which covers the
securities which the Company proposes to register; provided that if, at any
time after written notice of its intention to register any securities and prior
to the effective date of the registration statement filed in connection with
such registration, the Company determines for any reason either not to register
or to delay registration of such securities, the Company may, at its election,
give written notice of such determination to each holder of Registrable
Securities and, thereupon, (i) in the case of a determination not to
register, shall be relieved of this obligation to register any Registrable
Securities in connection with such registration (but not from its obligation to
pay the Registration Expenses in connection therewith), and (ii) in the
case of a determination to delay registering, shall be permitted to delay
registering any Registrable Securities, for the same period as the delay in
registering such other securities.  The
Company will pay all Registration Expenses in connection with each registration
of Registrable Securities requested pursuant to this Section 1.2.

1.3.          Priority In Incidental Registrations.  If the managing underwriter of an
underwritten offering informs the Company and holders of the Registrable
Securities requesting such registration by letter of its belief that the number
of securities requested to be included in such registration exceeds the number
which can be sold in such offering, then the Company will include in such
registration, to the extent of the number which the Company is so advised can
be sold in such offering, (i) first securities proposed by the Company to
be sold for its own account, and (ii) second securities of other selling
security holders requesting to be included in such registration if they hold
registration rights senior to those of the Investor, and (iii) third
Registrable Securities.

1.4.          Rule 415

(i)            The Investor expressly
acknowledges and agrees that since early 2006, the SEC staff has been raising
concerns regarding the availability of Rule 415 for resale shelf registrations
of privately placed securities, based primarily on Form S-3, Rule 415, the
Manual of Publicly Available Telephone Interpretations, and other guidance, and
that such concerns have caused significant uncertainty regarding the Company’s
ability to register for resale all of the shares of common stock subscribed for
in this offering, including shares underlying the warrants included in the
Interests (as defined in the Subscription Agreement).  As such, the Investor expressly acknowledges
and agrees that:

(ii)           any registration
statement filed that includes any shares included in the Interests may not be
declared effective by the SEC as a result of the SEC’s interpretation of Rule
415, that the Company may be required to cut back or reduce the number of
shares so registered, and that the Company will only register such number of
shares as permitted by the SEC;

(iii)          if there are to be
reductions to the number of shares to be registered (whether as a result of
Rule 415 issues or as a result of preexisting rights of holders of registration
rights whose

 2
 

rights may not be diluted by those of the investors
purchase Interests in this offering), then all investors purchasing Interests
in this offering may, in the sole discretion of the Company, have their shares
to be registered reduced pro rata with all other investors in this offering;

(iv)          if there are to be
reductions to the number of shares registered, then the Company will use its
commercially reasonable efforts to prepare and file follow-on registrations to
the extent permitted by existing SEC guidance (e.g. the later of sale by the
undersigned of substantially all of the shares previously registered and six
months) or based on the ability to register shares without SEC objection;

(v)           because any such
reduction or limitation is outside of the Company’s control, the undersigned
will have no right whatsoever to damages (liquidated or otherwise) for any
failure of the Company to register the undersigned’s shares timely, or at all,
because of Rule 415 related delays or objections made by, or limitations
imposed by, the SEC; and

(vi)          if a suit or action is
brought by any party under this Agreement against the Company for alleged
damages or loss resulting from Rule 415 related delays or objections made by,
or limitations imposed by, the SEC, then the Company will be entitled to its
attorneys fees and expenses incurred in responding to such suit or action.

ARTICLE II

REGISTRATION PROCEDURES

2.1.          Registration Procedures.  If and whenever the Company is required to
effect the registration of any Registrable Securities under the 1933 Act as
provided in Section 1.2, the Company shall, as expeditiously as possible:

(i)            prepare and file with
the SEC the Registration Statement, or amendments thereto, to effect such
registration and thereafter use its commercially reasonable efforts to cause
such registration statement to be declared effective by the SEC;

(ii)           with respect to any
registration statement pursuant to Section 1.2, prepare and file with the SEC
such amendments and supplements to such registration statement and the
prospectus used in connection therewith as may be necessary to keep such
registration statement effective and to comply with the provisions of the 1933
Act with respect to the disposition of all Registrable Securities covered by
such registration statement until the earlier to occur of thirty (30) months after
the date of this Agreement (subject to the right of the Company to suspend the
effectiveness thereof for not more than 30 consecutive Trading Days or an
aggregate of 30 Trading Days during each year (each a “Black-Out
Period”)) or such time as all of the securities which are the
subject of such registration statement cease to be Registrable Securities (such
period, in each case, the “Registration Maintenance
Period”);

(iii)          furnish to each holder
of Registrable Securities covered by such registration statement such number of
conformed copies of such registration statement and of each such amendment and
supplement thereto (in each case including all exhibits), such number of copies
of the prospectus contained in such registration statement (including each
preliminary prospectus and any summary prospectus) and any other prospectus
filed under Rule 424 under the 1933 Act, in conformity with the requirements of
the 1933 Act, and such other documents, as such holder

 3
 

of Registrable Securities and underwriter, if any, may
reasonably request in order to facilitate the public sale or other disposition
of the Registrable Securities owned by such holder of Registrable Securities;

(iv)          use its commercially
reasonable efforts to register or qualify all Registrable Securities and other
securities covered by such registration statement under such other U.S. federal
or state securities laws or U.S. state blue sky laws as any U.S. holder of
Registrable Securities thereof shall reasonably request, to keep such
registrations or qualifications in effect for so long as such registration
statement remains in effect, and take any other action which may be reasonably
necessary to enable such holder of Registrable Securities to consummate the disposition
in such jurisdictions of the securities owned by such holder of Registrable
Securities, except that the Company shall not for any such purpose be required
to qualify generally to do business as a foreign corporation in any
jurisdiction wherein it would not but for the requirements of this subdivision
(iv) be obligated to be so qualified or to consent to general service of
process in any such jurisdiction;

(v)           notify the Investor
promptly after the Company has knowledge thereof:

(a)           when the Registration
Statement, the prospectus or any prospectus supplement related thereto or
post-effective amendment to the Registration Statement has been filed, and,
with respect to the Registration Statement or any post-effective amendment
thereto, when the same has become effective;

(b)           of any request by the
SEC for amendments or supplements to the Registration Statement or the
prospectus or for additional information;

(c)           of the issuance by the
SEC of any stop order suspending the effectiveness of the Registration
Statement or the initiation of any proceedings by any person for that purpose;
and

(d)           of the receipt by the
Company of any notification with respect to the suspension of the qualification
of any Registrable Securities for sale under the securities or blue sky laws of
any jurisdiction or the initiation or threat of any proceeding for such
purpose;

(vi)          notify each holder of
Registrable Securities covered by such registration statement, at any time when
a prospectus relating thereto is required to be delivered under the 1933 Act,
upon discovery that, or upon the happening of any event as a result of which,
the prospectus included in such registration statement, as then in effect,
includes an untrue statement of a material fact or omits to state any material facts
required to be stated therein or necessary to make the statements therein not
misleading in the light of the circumstances then existing, and at the request
of any such holder of Registrable Securities promptly prepare and furnish to
such holder of Registrable Securities a reasonable number of copies of a
supplement to or an amendment of such prospectus as may be necessary so that,
as thereafter delivered to the purchasers of such securities, such prospectus
shall not include an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing; use its
best

 4
 

efforts to obtain the withdrawal of any order
suspending the effectiveness of the Registration Statement at the earliest
possible moment; and

(vii)         use its commercially
reasonable efforts to list all Registrable Securities covered by such
registration statement on any securities exchange on which any of the Registrable
Securities are then listed.

The Company may require each holder of Registrable
Securities as to which any registration is being effected to furnish the
Company such information regarding such holder of Registrable Securities and
the distribution of such securities as the Company may from time to time
reasonably request in writing.

2.2.          Each
holder of Registrable Securities agrees that, upon receipt of any notice from
the Company of the occurrence of any event of the kind described in subdivision
(vi) of Section 2.1, such Investor will forthwith discontinue the disposition
of Registrable Securities pursuant to the Registration Statement relating to
such Registrable Securities until such Investor’s receipt of the copies of the
supplemented or amended prospectus contemplated by subdivision (vi) of Section 2.1
and, if so directed by the Company, will deliver to the Company (at the Company’s
expense) all copies, other than permanent file copies, then in such Investor’s
possession of the prospectus relating to such Registrable Securities current at
the time of receipt of such notice.

ARTICLE III

UNDERWRITTEN OFFERINGS

3.1.          Incidental Underwritten Offerings.  If the Company at any time proposes to
register any of its securities under the 1933 Act as contemplated by
Section 1.2 and such securities are to be distributed by or through one or
more underwriters, the Company will, if requested by any holder of Registrable
Securities as provided in Section 1.2 and subject to the provisions of
Section 1.3 and Section 1.4, use its commercially reasonable efforts to
arrange for such underwriters to include all the Registrable Securities to be
offered and sold by such holder among the securities to be distributed by such
underwriters.

3.2.          Participation In Underwritten Offerings.  No holder of Registrable Securities may
participate in any underwritten offering under Section 3.1 unless such
holder of Registrable Securities (i) agrees to sell such person’s
securities on the basis provided in any underwriting arrangements approved,
subject to the terms and conditions hereof, by the holders of a majority of
Registrable Securities to be included in such underwritten offering and
(ii) completes and executes all questionnaires, indemnities, underwriting
agreements and other documents (other than powers of attorney) required under
the terms of such underwriting arrangements. 
Notwithstanding the foregoing, no underwriting agreement (or other
agreement in connection with such offering) shall require any holder of
Registrable Securities to make a representation or warranty to or agreements
with the Company or the underwriters other than representations and warranties
contained in a writing furnished by such holder of Registrable Securities
expressly for use in the related registration statement or representations,
warranties or agreements regarding such holder of Registrable Securities, such
holder’s Registrable Securities and such holder’s intended method of
distribution and any other representation required by law.

 5
 

3.3.          Preparation; Reasonable Investigation.  In connection with the preparation and filing
of each registration statement under the 1933 Act pursuant to this Agreement,
the Company will give the holders of Registrable Securities registered under
such registration statement, and their respective counsel and accountants, the
opportunity to review any registration statement, each prospectus included
therein or filed with the SEC, and each amendment thereof or supplement
thereto, and will give each of them such access to its books and records and
such opportunities to discuss the business of the Company with its officers and
the independent public accountants who have certified its financial statements
as shall be necessary, in the reasonable opinion of such holders’ and such underwriters’
respective counsel, to conduct a reasonable investigation within the meaning of
the 1933 Act.

ARTICLE IV

INDEMNIFICATION

4.1.          Indemnification by the Company.  In the event of any registration of any
securities of the Company under the 1933 Act, the Company will, and hereby does
agree to indemnify and hold harmless the holder of any Registrable Securities
covered by such registration statement against any losses, claims, damages or
liabilities, joint or several, to which such holder may become subject under
the 1933 Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions or proceedings, whether commenced or threatened, in
respect thereof) arise out of or are based upon any untrue statement or alleged
untrue statement of any material fact contained in any registration statement
under which such securities were registered under the 1933 Act, any preliminary
prospectus, final prospectus or summary prospectus contained therein, or any
amendment or supplement thereto, or any omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, and the Company will reimburse such holder
and each such director, officer, underwriter and controlling person for any
legal or any other expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, liability, action or
proceeding; provided that the Company shall not be liable in any such case to
the extent that any such loss, claim, damage, liability, (or action or
proceeding in respect thereof) or expense arises out of or is based upon an
untrue statement or alleged untrue statement or omission or alleged omission
made in such registration statement, any such preliminary prospectus, final
prospectus, summary prospectus, amendment or supplement in reliance upon and in
conformity with written information furnished to the Company by such holder or
underwriter stating that it is for use in the preparation thereof and, provided
further that the Company shall not be liable to any person who participates as
an underwriter in the offering or sale of Registrable Securities or to any
other person, if any, who controls such underwriter within the meaning of the
1933 Act, in any such case to the extent that any such loss, claim, damage,
liability (or action or proceeding in respect thereof) or expense arises out of
such person’s failure to send or give a copy of the final prospectus, as the
same may be then supplemented or amended, within the time required by the 1933
Act to the person asserting the existence of an untrue statement or alleged
untrue statement or omission or alleged omission at or prior to the written
confirmation of the sale of Registrable Securities to such person if such
statement or omission was corrected in such final prospectus or an amendment or
supplement thereto.

4.2.          Indemnification by the Investor.  The Company may require, as a condition to
including any Registrable Securities in any registration statement filed
pursuant to this

 6
 

Agreement, that the Company shall have received an
undertaking satisfactory to it from the prospective holder of such Registrable
Securities, to indemnify and hold harmless (in the same manner and to the same
extent as set forth in Section 4.1) the Company, each director of the Company,
each officer of the Company, its employees, affiliates, attorneys and agents, and
each other person, if any, who controls the Company within the meaning of the
1933 Act, with respect to any statement or alleged statement in or omission or
alleged omission from such registration statement, any preliminary prospectus,
final prospectus or summary prospectus contained therein, or any amendment or
supplement thereto, if such statement or alleged statement or omission or
alleged omission was made in reliance upon and in conformity with written
information furnished to the Company through an instrument duly executed by
such holder of Registrable Securities specifically stating that it is for use
in the preparation of such registration statement, preliminary prospectus,
final prospectus, summary prospectus, amendment or supplement.  Any such indemnity shall remain in full force
and effect, regardless of any investigation made by or on behalf of the Company
or any such director, officer or controlling person and shall survive the
transfer of such securities by such Investor.

4.3.          Notices Of Claims, Etc.  Promptly after receipt by an indemnified
party of notice of the commencement of any action or proceeding involving a
claim referred to in Section 4.1 and Section 4.2, such indemnified
party will, if claim in respect thereof is to be made against an indemnifying
party, give written notice to the latter of the commencement of such action,
provided that the failure of any indemnified party to give notice as provided
herein shall not relieve the indemnifying party of its obligations under
Section 4.1 and Section 4.2, except to the extent that the
indemnifying party is actually prejudiced by such failure to give notice.  In case any such action is brought against an
indemnified party, unless in such indemnified party’s reasonable judgment a
conflict of interest between such indemnified and indemnifying parties may
exist in respect of such claim, the indemnifying party shall be entitled to
participate in and to assume the defense thereof, jointly with any other
indemnifying party similarly notified, to the extent that the indemnifying
party may wish, with counsel reasonably satisfactory to such indemnified party,
and after notice from the indemnifying party to such indemnified party of its
election so to assume the defense thereof, the indemnifying party shall not be
liable to such indemnified party for any legal or other expenses subsequently
incurred by the latter in connection with the defense thereof other than
reasonable costs of investigation.  No
indemnifying party shall, without the consent of the indemnified party, consent
to entry of any judgment or enter into any settlement of any such action which
does not include as an unconditional term thereof the giving by the claimant or
plaintiff to such indemnified party of a release from all liability, or a
covenant not to sue, in respect to such claim or litigation.  No indemnified party shall consent to entry
of any judgment or enter into any settlement of any such action the defense of
which has been assumed by an indemnifying party without the consent of such
indemnifying party.

4.4.          Other Indemnification.  Indemnification similar to that specified in Section
4.1 and Section 4.2 (with appropriate modifications) shall be given by the
Company and each holder of Registrable Securities (but only if and to the
extent required pursuant to the terms herein) with respect to any required
registration or other qualification of securities under any Federal or state
law or regulation of any governmental authority, other than the 1933 Act.

 7
 

4.5.          Contribution.  If the indemnification provided for in Sections 4.1
4.2 and Section 4.3 is unavailable to an indemnified party in respect of
any expense, loss, claim, damage or liability referred to therein, then each
indemnifying party, in lieu of indemnifying such indemnified party, shall
contribute to the amount paid or payable by such indemnified party as a result
of such expense, loss, claim, damage or liability (i) in such proportion
as is appropriate to reflect the relative benefits received by the Company on
the one hand and the holder of Registrable Securities or underwriter, as the
case may be, on the other from the distribution of the Registrable Securities
or (ii) if the allocation provided by clause (i) above is not
permitted by applicable law, in such proportion as is appropriate to reflect
not only the relative benefits referred to in clause (i) above but also the
relative fault of the Company on the one hand and of the holder of Registrable
Securities or underwriter, as the case may be, on the other in connection with
the statements or omissions which resulted in such expense, loss, damage or
liability, as well as any other relevant equitable considerations.  The relative benefits received by the Company
on the one hand and the holder of Registrable Securities or underwriter, as the
case may be, on the other in connection with the distribution of the
Registrable Securities shall be deemed to be in the same proportion as the
total net proceeds received by the Company from the initial sale of the
Registrable Securities by the Company to the purchasers bear to the gain, if
any, realized by all selling holders participating in such offering or the
underwriting discounts and commissions received by the underwriter, as the case
may be.  The relative fault of the
Company on the one hand and of the holder of Registrable Securities or
underwriter, as the case may be, on the other shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a
material fact or omission to state a material fact relates to information
supplied by the Company, by the holder of Registrable Securities or by the
underwriter and the parties’ relative intent, knowledge, access to information
supplied by the Company, by the holder of Registrable Securities or by the
underwriter and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission, provided that
the foregoing contribution agreement shall not inure to the benefit of any
indemnified party if indemnification would be unavailable to such indemnified
party by reason of the provisions contained herein, and in no event shall the
obligation of any indemnifying party to contribute under this Section 4.5
exceed the amount that such indemnifying party would have been obligated to pay
by way of indemnification if the indemnification provided for hereunder had been
available under the circumstances.

The Company and the holders of Registrable Securities
agree that it would not be just and equitable if contribution pursuant to this
Section 4.5 were determined by pro rata allocation (even if the holders of
Registrable Securities and any underwriters were treated as one entity for such
purpose) or by any other method of allocation that does not take account of the
equitable considerations referred to in the immediately preceding paragraph.  The amount paid or payable by an indemnified
party as a result of the losses, claims, damages and liabilities referred to in
the immediately preceding paragraph shall be deemed to include, subject to the
limitations set forth herein, any legal or other expenses reasonably incurred by
such indemnified party in connection with investigating or defending any such
action or claim.

Notwithstanding the provisions of this Section 4.5,
no holder of Registrable Securities or underwriter shall be required to
contribute any amount in excess of the amount by which (i) in the case of
any such holder, the net proceeds received by such holder from the sale of
Registrable Securities in the applicable Registration Statement or (ii) in
the case of an underwriter, the total

 8
 

price at which the Registrable Securities purchased by
it and distributed to the public were offered to the public exceeds, in any
such case, the amount of any damages that such holder or underwriter has
otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission.  No person guilty
of fraudulent misrepresentation (within the meaning of Section 11(f) of
the 1933 Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation.

ARTICLE V

MISCELLANEOUS

5.1.          Amendments And Waivers.  This Agreement may be amended and the Company
may take any action herein prohibited, or omit to perform any act herein
required to be performed by it, only if the Company shall have obtained the
written consent to such amendment, action or omission to act, of the holder or
holders of the sum of the fifty-one percent (51%) or more of the shares of
Registrable Securities issued at such time. 
Each holder of any Registrable Securities at the time or thereafter
outstanding shall be bound by any consent authorized by this Section 5.1,
whether or not such Registrable Securities shall have been marked to indicate
such consent.

5.2.          Nominees For Beneficial Owners.  In the event that any Registrable Securities
are held by a nominee for the beneficial owner thereof, the beneficial owner
thereof may, at its election, be treated as the holder of such Registrable
Securities for purposes of any request or other action by any holder or holders
of Registrable Securities pursuant to this Agreement or any determination of
any number of percentage of shares of Registrable Securities held by a holder
or holders of Registrable Securities contemplated by this Agreement.  If the beneficial owner of any Registrable
Securities so elects, the Company may require assurances reasonably
satisfactory to it of such owner’s beneficial ownership or such Registrable
Securities.

5.3.          Notices.  Except as otherwise provided in this
Agreement, all notices, requests and other communications to any person
provided for hereunder shall be in writing and shall be given to such person
(a) in the case of a party hereto other than the Company, addressed to
such party in the manner set forth in the Subscription Agreement or at such
other address as such party shall have furnished to the Company in writing, or
(b) in the case of any other holder of Registrable Securities, at the
address that such holder shall have furnished to the Company in writing, or,
until any such other holder so furnishes to the Company an address, then to and
at the address of the last holder of such Registrable Securities who has
furnished an address to the Company, or (c) in the case of the Company, at
the address set forth on the signature page hereto, to the attention of its
President, or at such other address, or to the attention of such other officer,
as the Company shall have furnished to each holder of Registrable Securities at
the time outstanding.  Each such notice,
request or other communication shall be effective (i) if given by mail, 72
hours after such communication is deposited in the mail with first class
postage prepaid, addressed as aforesaid or (ii) if given by any other
means (including, without limitation, by fax or air courier), when delivered at
the address specified above, provided that any such notice, request or
communication shall not be effective until received.

5.4.          Assignment.  This Agreement shall be binding upon and
inure to the benefit of and be enforceable by the parties hereto.  In addition, and whether or not any express
assignment shall have been made, the provisions of this Agreement which are for
the benefit of the parties hereto

 9
 

other than the Company shall also be for the benefit
of and enforceable by any subsequent holder of any Registrable Securities.

5.5.          Descriptive Headings.  The descriptive headings of the several
sections and paragraphs of this Agreement are inserted for reference only and
shall not limit or otherwise affect the meaning hereof.

5.6.          Governing Law.  This Agreement shall be governed by, and
construed in accordance with, the laws of the State of Colorado, without giving
effect to applicable principles of conflicts of law.

5.7.          Jurisdiction.  If any action is brought among the parties
with respect to this Agreement or otherwise, by way of a claim or counterclaim,
the parties agree that in any such action, and on all issues, the parties
irrevocably waive their right to a trial by jury.  Exclusive jurisdiction and venue for any such
action shall be the State or Federal Courts located in the City and County of
Denver, Colorado.  In the event suit or
action is brought by any party under this Agreement to enforce any of its
terms, or in any appeal therefrom, it is agreed that the prevailing party shall
be entitled to reasonable attorneys fees to be fixed by the arbitrator, trial
court, and/or appellate court.

5.8.          Entire Agreement.  This Agreement embodies the entire agreement
and understanding between the Company and each other party hereto relating to
the subject matter hereof and supercedes all prior agreements and
understandings relating to such subject matter.

5.9.          Severability.  If any provision of this Agreement, or the
application of such provisions to any person or circumstance, shall be held
invalid, the remainder of this Agreement, or the application of such provision
to persons or circumstances other than those to which it is held invalid, shall
not be affected thereby.

5.10.        Binding Effect.  All the terms and provisions of this
Agreement whether so expressed or not, shall be binding upon, inure to the benefit
of, and be enforceable by the parties and their respective administrators,
executors, legal representatives, heirs, successors and assignees.

5.11.        Preparation of Agreement.  This Agreement shall not be construed more
strongly against any party regardless of who is responsible for its
preparation.  The parties acknowledge
each contributed and is equally responsible for its preparation.

5.12.        Failure or Indulgence Not
Waiver; Remedies Cumulative. 
No failure or delay on the part of any party hereto in the exercise of
any right hereunder shall impair such right or be construed to be a waiver of,
or acquiescence in, any breach of any representation, warranty, covenant or
agreement herein, nor shall nay single or partial exercise of any such right
preclude other or further exercise thereof or of any other right.  All rights and remedies existing under this
Agreement are cumulative to, and not exclusive of, any rights or remedies
otherwise available.

5.13.        Counterparts.  This Agreement may be executed in one or more
counterparts, and by the different parties hereto in separate counterparts,
each of which when executed shall be deemed to be an original, but all of which
taken together shall constitute one and the same agreement.  A facsimile transmission of this signed
Agreement shall be legal and binding on all parties hereto.

 10
 

[SIGNATURES ON FOLLOWING PAGE]

 11
 

IN WITNESS WHEREOF, the Investor
and the Company have as of the date first written above executed this
Agreement.

Corgenix Medical Corporation

	
  

  	
   

  
	
  By: Douglass T. Simpson

  
	
  Title: Chief
  Executive Officer

  
	
   

  
	
  INVESTOR

  
	
   

  
	
  [Insert Name and
  signature block]

  

 

 12Exhibit
4.4

PLACEMENT AGENT
AGREEMENT

June 14, 2007

Dear Sirs:

The undersigned, Corgenix
Medical Corporation, a Nevada corporation (the “Company”), hereby confirms its
agreement with Terra Nova Financial, LLC, an Illinois limited liability corporation
(the “Placement Agent”), as follows:

1.             Introduction.  The Company intends to offer for sale and
sell to a limited number of persons, each of whom (a) is an “accredited
investor” as defined in Rule 501 of Regulation D (“Regulation D”) under the
Securities Act of 1933, as amended (the “1933 Act”), and (b) meets the
standards that are set forth in the Private Placement Marketing materials dated
             (together
with any exhibits, cover letters, amendments and supplements thereto, the “Marketing
Materials”) under the caption “Investor Suitability” (“Investors”), $650,000 of
equity securities, or options, warrants, or rights to acquire equity securities
convertible into or exchangeable for equity securities (the “Securities”) of the
Company, pursuant to the terms of the Marketing Materials (the “Offering”), and
subject to the approval of the Company’s Board of Directors.  The Placement Agent may not be the Company’s
exclusive sales agent in connection with the Offering and the Company may make
sales directly to investors, engage other placement agents or may engage other
qualified broker-dealers (“Selected Dealers”) to assist in the Offering.

This Agreement sets forth the
understandings and agreements between the Company and the Placement Agent
whereby, subject to the terms and conditions herein contained, the Placement
Agent will solicit offers and obtain purchases for the Securities.

2.             Representations
and Warranties of the Company.  The
Company represents and warrants to, and agrees with, the Placement Agent that:

2.1.          No Registration of the Securities; Regulation D;
Compliance with Securities Laws.

2.1.1.       The Securities are
not required to be and have not and will not be registered with the Securities
and Exchange Commission (the “Commission”) pursuant to the 1933 Act, and the
rules and regulations promulgated thereunder in connection with the
Offering.  The Securities will be offered
and sold in reliance upon the exemption provided by Section 4(2) of the 1933
Act and Rule 506 of Regulation D.  The Company
has complied with and will comply with the requirements of Section 4(2) of the
1933 Act and Rule 506 of Regulation D in connection with the Offering.

2.1.2.       No registration
statement relating to the Securities has been filed under the securities laws
of any state, except as required to obtain exemptions from regulation of public
securities offerings.  The Securities
will be offered and sold in reliance upon applicable exemptions from
registration under the laws, regulations and policy statements of the Blue Sky
States (as defined in Section 4.3.1 hereof).

2.1.3.       For the purposes of
this Agreement, the term “Affiliate” means, when used with reference to a
specified person, (a) any person or entity directly or indirectly controlling,
controlled by or under common control with such specified person, and (b) any
officer, director or general partner of an entity referred to in clause
(a).  The term “control” shall mean the
power to direct the management and policies of a person, directly or through
one or more intermediaries, whether through the ownership of voting securities,
by contract, or otherwise.

2.2.          Organization; Good Standing of the Company.  The Company is a duly organized and validly
existing corporation in good standing under the laws of the State of Nevada
with full power and authority to acquire, own, lease and manage its properties
and assets and to conduct the business in which it is engaged, and is qualified
to do business and is in good standing as a foreign corporation in each
jurisdiction in which its ownership of property or the conduct of its business
requires such qualification, except such jurisdictions where the failure to so
qualify would not have a material adverse effect on its business, properties or
condition (financial or otherwise).

3.             Sales
of Securities.

3.1.          Agency.  On
the basis of the representations, warranties and covenants contained herein and
subject to the terms and conditions set forth herein, the Company hereby
appoints the Placement Agent as its non-exclusive agent for the period
beginning on the date of this Agreement and ending on August 31, 2007, subject
to extension by the Company (the “Offering Period”), subject to the earlier
termination in accordance with the terms hereof for the limited purpose of
soliciting subscriptions (the “Subscriptions”) from prospective investors.  On the basis of the representations,
warranties and covenants contained herein, and subject to the terms and
conditions set forth herein, the Placement Agent shall use its best efforts as
agent to obtain the Subscriptions.  In
connection therewith, the Placement Agent will not offer any Securities for
sale, or solicit any Subscription other than in accordance with the Offering.

3.2.          Termination Date. 
At the close of business on the last day of the Offering Period (the “Termination
Date”), the obligations of the Placement Agent hereunder to use its best
efforts as agent to obtain Subscriptions shall terminate.

3.3.          Price; Minimum Purchase.  The offering price and terms for each Security
shall be set forth in the Offering at the sole discretion of the Board of
Directors, and must not cause any default, event of default, etc. under any of
the Company’s currently operative agreements with 

 2
 

respect to any note or preferred stock.  The minimum purchase requirement for an
Investor shall be set forth in the Offering, subject to waiver by the Board of
Directors.  For the avoidance of doubt,
the Company will have no obligation to issue any Security unless the terms,
conditions, timing and all other aspects of any Offering are acceptable to the
Board of Directors in its sole discretion.

3.4.          Acceptance of Subscriptions.  No Subscription shall be effective unless
accepted by the Company.  Securities
Purchase Agreements must be executed by Investors.  The Securities shall be offered subject to
prior sale.  The Company retains the
unconditional right to reject any Subscription in whole or in part; in such
event, the funds delivered by the Investor thereunder with respect to such
Subscription shall be returned to such Investor as promptly as practicable, and
in such event, no interest on such funds shall be paid to such Investor.

3.5.          Initial Closing Date.  If the Securities Purchase Agreements for Securities
has been received and accepted on or before the Termination Date (the “Initial
Closing Date”), the Placement Agent will deliver to the Company immediately
available funds in an amount equal to the amount so subscribed for on the
Initial Closing Date, except for the commissions and fees payable to the
Placement Agent calculated in accordance with Section 3.7 hereof with respect
to the aggregate amount of all Securities purchased and paid for at the Initial
Closing Date.

3.6.          Additional
Closing Dates.  If, after the Initial
Closing Date and on or before the Termination Date, additional sales of Securities
are made and Securities Purchase Agreements are accepted by the Company, on
each such date or dates and at such times and places as are determined by the
Company (which determinations shall be subject to the satisfaction on each such
date of the conditions contained herein) (“Additional Closing Dates”), the
Placement Agent will deliver to the Company immediately available funds in an
amount equal to the amount so subscribed for on such Additional Closing Date,
except for the commissions and fees payable to the Placement Agent calculated
in accordance with Section 3.8 hereof with respect to the aggregate amount of
all Securities purchased and paid for on each such Additional Closing
Date.  The last Additional Closing Date shall
not be later than five business days following the Termination Date unless
extended by mutual agreement of the Placement Agent and the Company.  The Additional Closing Dates and the Initial
Closing Date are herein referred to collectively as the “Closing Dates.”  The last Additional Closing Date shall be
referred to as the “Final Closing Date.”

3.7           Selected
Dealers.  The Company may, in its
sole discretion, engage Selected Dealers, who are members of the National
Association of Securities Dealers, Inc. in connection with the Offering, on
such basis and for such compensation as it may determine.

3.8.          Placement
Fee.  In consideration for the
Placement Agent’s execution of this Agreement and for the performance of its
obligations hereunder, the Placement Agent shall receive from the Company on
each of the Closing Dates and at additional times as set forth in Section 3.9 a
placement fee equal to seven percent (7%) of the aggregate offering price of
all 

 3
 

Securities sold on such Closing Date and within the twelve
(12) month period following the Termination Date (if any post Termination Date
sales are made to investors located by the Placement Agent prior to the
Termination Date and made known to the Company in writing only by Placement
Agent’s efforts prior to the Termination Date). 
The Company shall also allocate and grant to Placement Agent warrants to
purchase stock in the Company at the offering price.  The number of warrants, and the warrant
price, shall be based upon: (i) the valuation of the Company’s stock at the
time of the closing of the transaction, and (ii) an aggregate value equal to seven
percent (7%) of the total amount of funds raised for the Company by Placement
Agent through the twelve (12) month period following the Termination Date.

3.9.          Additional
Fees. In the event that any individual investor purchasing Securities from the
Company shall purchase additional Securities from the Company or holds debt in
the Company within twelve (12) months from the Termination Date, the Company
will pay to Placement Agent any and all fees owed pursuant to Section 3.8.

3.10.        The
Company To Pay Certain Fees and Expenses. 
The Company shall bear all of its own costs and expenses in connection
with the transactions contemplated hereby, including, but not limited to,
expenses (i) for consulting, legal, financial, printing, auditing, and
accounting services related to the Offering, (ii) in connection with the
Company’s responsibilities under Section 4.3 hereof (regarding blue sky
qualification) and (iii) for engraving, issuance, transfer and delivery
(including payment of any applicable transfer tax) of certificates evidencing
the Securities.  The Company will, upon
request, reimburse the Placement Agent for all reasonable out-of-pocket costs
and expenses incurred by Placement Agent in performing its obligations under
this Agreement, which costs and expenses shall include, but not be limited to,
travel expenses, expenses incurred in performing due diligence in connection
with transactions, legal expenses, and all other expenses reasonably incurred
by Placement Agent in performing its obligations under this Agreement;
provided, however, that Placement Agent shall obtain the prior approval of the
Company for any single expenditure in excess of $10,000.  In seeking reimbursement for expenses,
Placement Agent shall provide to the Company a written statement or statements
detailing expenses for which reimbursement is sought and, upon request, by the
Company, shall provide copies of invoices and other documentation supporting
such expenses.  Reimbursable expenses
shall by payable by the Company within ten (10) days of receipt by the Company
of such written statement or, if requested by the Company, copies of supporting
documentation.  In addition, the Company
shall be responsible for (i) the costs and fees associated with the filing of
the offering materials with the NASD (including all required COBRADesk fees)
and (ii) legal fees incurred by Placement Agent in connection with the
COBRADesk filings.  Such amounts shall
come from the proceeds received in the Offering and shall be paid at the
initial closing of the Offering.

3.11         Right
of First Refusal on Subsequent Offering. 
Subject to the rights of various investors pursuant to certain
Securities Purchase Agreements dated May 19, 2005 and December 28, 2005 with Barron
Partners, LLP, Truk International Fund, LP, Truk Opportunity Fund, LLC and
CAMOFI Master LDC (f/k/a DCOFI Master LDC): 
In consideration for Placement Agent’s successfully raising $650,000 of
funds in connection with the Offering, the Company will 

 4
 

provide Placement Agent with the right of first
refusal to serve as the exclusive representative to the Company for a future
offering whether a private placement (common, preferred, or convertible equity,
or debt securities) or a registered secondary offering, subsequent to the
private placement contemplated under this Agreement, in the approximate amount
of $3.0 to $4.0 million.  “Successfully
raising $650,000 of funds” by Placement Agent, as contemplated under this Section,
shall be defined as Placement Agent obtaining Subscriptions for a minimum of 90%
of the $650,000 of funds to be raised (at least $585,000) in connection with
the Offering by Placement Agent.  The
Company shall extend the right of first refusal to Placement Agent for a period
of twelve (12) months following the date that the Company has received at least
the $585,000 in cash funds noted above from the Offering under this Agreement.

4.             Covenants
of the Company.  The Company covenants
and agrees with the Placement Agent as follows:

4.1.          Preparation of Marketing Materials.  The Company will prepare the Marketing Materials,
including but not limited to the Offering, most recent Proxy, Forms 10-QSB and
Form 10-KSB, recent press releases, power point, and a company profile/fact
sheet.

4.2.          Delivery of Marketing Materials and Other Documents.  The Company will deliver to the Placement
Agent, as soon as practicable, such reasonable number of copies of the Marketing
Materials as the Placement Agent may reasonably request for purposes
contemplated herein.  The Company will
also deliver to the Placement Agent, as soon as practicable, such numbers of
copies of the Subscription Agreement and Confidential Purchaser Questionnaire
(natural persons).as the Placement Agent may reasonably request.

4.3.          Blue Sky Qualification.

4.3.1.       At or prior to the
beginning of the Offering Period, the Company shall use its best efforts to
qualify or register for sale the Securities or to seek an exemption of the Securities
from qualification or registration, for offering and sale under the laws of
such jurisdictions in the United States as the Company reasonably may determine
(the “Blue Sky States”), with the number of Securities to be so qualified in
each such jurisdiction being as determined by the Company and thereafter to
maintain such qualification in effect until the Termination Date.

4.3.2.       The Company shall
have the responsibility for the filing of material in connection with the
offering and sale of the Securities to qualify the Securities or to establish
an exemption from qualification for the Securities with the proper authorities
in the Blue Sky States.  The Placement
Agent will cooperate with the Company in making such filings or obtaining such qualifications.  The Placement Agent will furnish to the
Company all information pertaining to the Placement Agent reasonably requested
by the Company to comply with the laws and regulations of the Blue Sky
States.  Any materials so furnished 

 5
 

will not contain any misstatement of a material fact or omit to state
any material fact necessary to make any statement of fact contained therein not
misleading.

4.4.          Distribution of Additional Information.  Subject to the Company’s right to require
confidential treatment by Investors of its proprietary information, the Company
will, during the Offering Period, make available to each prospective Investor,
and any individual advising such Investor, all information required to be
furnished by Regulation D and applicable state securities laws pertaining to the
Company and the Offering, and will give such prospective Investor and any
person advising such prospective Investor the opportunity to ask questions and
receive answers concerning the Company and the Offering and to obtain any
additional information, to the extent such information is in the possession of the
Company or can be acquired without unreasonable effort or expense, as is
necessary to verify the accuracy of the information contained in the Marketing Materials.

5.             Representations,
Warranties and Covenants of Placement Agent.  The Placement Agent represents and warrants
to, and covenants with the Company that:

5.1.          Solicitation
of Investors.

5.1.1.       The Placement Agent
shall use its best efforts to locate a limited number of Investors who desire the
opportunity to purchase Securities pursuant to the Offering.  So far as is under the Placement Agent’s
control, the offer and sale of Securities shall be made in reliance upon the
exemption from the registration requirements of Section 5 of the 1933 Act
provided by Regulation D and other administrative rules and regulations
interpreting Section 4(2) of the 1933 Act, and the exemptive provisions of
applicable state securities laws.

5.1.2.       The Placement Agent
shall provide a copy of the Marketing Materials to each Investor prior to
soliciting any offers to subscribe for or offers to purchase any Securities.  The Placement Agent is not authorized to and
shall not give any information or make any representations other than as
contained in the Offering.  The Placement
Agent will only provide copies of the Marketing Materials to the Investors
listed in writing in a letter to the Company and its counsel by name, address
and Marketing Materials copy number.

5.1.3.       Before offering the Securities
for sale to any Investor, the Placement Agent shall have reasonable grounds to
believe and will believe that the Investor (a) meets the standards which are
set forth in the Offering summary under the caption “Investor Suitability”, (b)
information contained in the Subscription Agreement and Stock Purchase
Agreement relating to such Investor is true and correct in all material
respects, and (c) will be acquiring the Securities for his own account and not
for the account of, or on behalf of, other persons.

 6
 

5.1.4.       The Placement Agent
shall not offer or sell the Securities by means or form of general solicitation
or advertising within the meaning of Rule 502(c) of Regulation D, including,
but not limited to:  (a) any
advertisement, article, notice or other communication published in any
newspaper, magazine or similar news medium or broadcast over television or
radio, and (b) any seminar or meeting whose attendees have been invited by any
general solicitation or general advertising.

5.1.5.       The Placement Agent
shall solicit purchases of Securities only in states in which the Placement
Agent has been advised by counsel for the Company that such solicitation can be
made and in which the Placement Agent is qualified to so act, and such
solicitations shall be made subject to any conditions set forth by such
counsel.  The participation and
acceptance of compensation by the Placement Agent or its Affiliates in
connection with the sale of the Securities shall not result in a violation of
Section 4(2) of the 1933 Act, Regulation D or any state securities laws.

5.1.6        The Placement Agent
shall control the distribution of copies of the Marketing Materials in
accordance with applicable state and federal securities laws.

5.2           Information with Respect to Potential Investors.  The Placement Agent shall make available to the
Company and its counsel such information in the Placement Agent’s possession as
the Company may reasonably request with respect to the knowledge and experience
in financial and business matters of each Investor and its representative, if
any, the ability of the Investor to bear the economic risk of an investment in
the Securities, and its knowledge and experience in financial and business
matters.  Moreover, the Placement Agent
shall not submit any executed Securities Purchase Agreement to the Company for
consideration unless, after making reasonable inquiry, the Placement Agent
shall have reasonable grounds to believe and shall believe that the Investor
meets the standards that are set forth in the Offering under the caption “Investor
Suitability”.

5.3           Amendments to Marketing Materials.  Until the end of the Offering Period, if any
event affecting the Offering or the Company shall occur which should be set
forth in a supplement or amendment to the Marketing Materials, the Placement Agent
agrees, upon receipt of such supplement or amendment from the Company, to
distribute such supplement or amendment to each person who has previously
received a copy of the Marketing Materials from the Placement Agent and who
continues to be interested in the Offering, unless the Company shall have
advised the Placement Agent that Securities will not be sold to such
person.  The Placement Agent further
agrees to include such supplement or amendment in all subsequent deliveries of
the Marketing Materials.

5.4           Broker-Dealer. 
The Placement Agent is a broker-dealer registered with the Securities
and Exchange Commission under the Securities Exchange Act of 1934, as amended
(the “Exchange Act”) and in each state in which each Investor resides and is a
member in good standing of the National Association of Securities Dealers,
Inc.  Each agent of the Placement Agent
is a 

 7
 

registered representative under the Exchange Act and
in each state in which each Investor resides, as applicable.

5.5           IRA Sales. 
Each purchase of Securities by an individual retirement account shall be
made in accordance with such procedures and shall be accompanied by such
documentation as the Placement Agent shall have established for such
circumstances.

5.6           Public Disclosure. 
The Placement Agent shall not disclose to anyone (other than the
Investors) that it has served as a placement agent in this transaction or any
other transaction with the Company, the terms of this Agreement, the contents
of the Marketing Materials or any other information it has received in
connection with the Offering, except with the prior written consent of the
Company.

6.             Conditions
Precedent to Placement Agent’s Obligations. 
The obligations of the Placement Agent hereunder shall be subject to the
continued accuracy throughout the Offering Period of the representations,
warranties and agreements of the Company, and to the performance by the Company
in all respects of its obligations hereunder.

7.             Conditions
Precedent to the Company’s Obligations. 
The obligations of the Company to continue the Placement Agent’s
engagement pursuant to this Agreement shall be subject to the accuracy in all
material respects, as of the date hereof and through each Closing Date, of the
representations, warranties and agreements of the Placement Agent, and to the
performance by the Placement Agent in all respects of its obligations
hereunder.

8.             Representations,
Warranties, Covenants and Agreements to Survive.  Except as the context otherwise requires, all
representations, warranties, any agreements made in Section 2 hereof, covenants
and agreements contained in this Agreement (including but not limited to
Section 3.11 and Section 9.2) shall remain operative and in full force and
effect regardless of any investigation made by or on behalf of the Placement
Agent, the Company, or by any controlling person of either, and shall survive
the Termination Date.

9.                                     Indemnification.

9.1           Indemnification by Placement Agent.  The Placement Agent agrees to indemnify and
hold harmless the Company (and each other person, if any, who controls the
Company within the meaning of Section 15 of the 1933 Act, each officer of the Company
who signs a registration statement and each director of the Company) from and
against any losses, claims, damages, judgments, liabilities, expenses, or costs
(and all actions in respect thereof and any legal or other expenses in giving
testimony or furnishing documents in response to a subpoena or otherwise),
including the cost of investigating, preparing for, or defending any such action
or claim, whether or not in connection with litigation to which the Company (or
any such officer, director or controlling person) may become subject (under the
1933 Act or otherwise), insofar as such losses, claims, 

 8
 

damages or liabilities (or actions or proceedings in
respect thereof) arise out of, or are based upon, any failure of the Placement
Agent to comply with its covenants and agreements contained herein or any
misrepresentation herein and the Placement Agent promptly will reimburse the Company
(or such officer, director or controlling person), as the case may be, for any
legal or other expenses reasonably incurred in investigating, defending or
preparing to defend any such action, proceeding or claim.

9.2           Indemnification by the Company.  The Company agrees to indemnify and hold
harmless the Placement Agent together with its affiliates, directors, officers,
agents, and employees (“Indemnified Person”) from and against any losses,
claims, damages, judgments, liabilities, expenses, or costs (and all actions in
respect thereof and any legal or other expenses in giving testimony or
furnishing documents in response to a subpoena or otherwise), including the
cost of investigating, preparing for, or defending any such action or claim,
whether or not in connection with litigation to which the Indemnified Person may
become subject (under the 1933 Act or otherwise), insofar as such losses,
claims, damages or liabilities (or actions or proceedings in respect thereof)
arise out of, or are based upon, any failure of the Company to comply with its
covenants and agreements contained herein or any misrepresentation herein or
otherwise arising out of the Company’s acts or omissions and the Company
promptly will reimburse the Placement Agent for any legal or other expenses
reasonably incurred in investigating, defending or preparing to defend any such
action, proceeding or claim.

9.3           Indemnification Procedure.  Promptly after receipt by any indemnified
person of a notice of a claim or the beginning of any action in respect of
which indemnity is to be sought against an indemnifying person pursuant to
Section 9.1 or 9.2, such indemnified person shall notify the indemnifying
person in writing of such claim or of the commencement of such action, and,
subject to the provisions hereinafter stated, in case any such action shall be
brought against an indemnified person, such indemnifying person shall be
entitled to participate therein, and, to the extent it shall wish, to assume
the defense thereof, with counsel reasonably satisfactory to such indemnified
person.  After notice from the
indemnifying person to such indemnified person of its election to assume the
defense thereof, such indemnifying person shall not be liable to such indemnified
person for any legal expenses subsequently incurred by such indemnified person
in connection with the defense thereof, provided, however, that if there exists
or shall exist an actual or potential conflict of interest that would make it
inappropriate, in the opinion of counsel to the indemnified person, for the
same counsel to represent both the indemnified person and such indemnifying
person or any affiliate or associate thereof, the indemnified person shall be
entitled to retain its own counsel at the expense of such indemnifying person;
provided, however, that no indemnifying person shall be responsible for the
fees and expenses of more than one separate counsel for all indemnified
parties.

10.           Effective
Date and Termination of Agreement.

10.1         Effective Date. 
This Agreement shall become effective as of the date of execution 

 9
 

hereof.

10.2         Failure to Fulfill Conditions.  In the event that either party fails to
fulfill (the “Non-Fulfilling Party”) any of the conditions precedent to the
performance of the obligations of the other party (the “Other Party”), the
Other Party shall elect to either (a) waive such unfulfilled condition or
conditions and consummate the transaction which is the subject hereof, in which
event no claim may be asserted against the Non-Fulfilling Party by reason of
the matters which were the subject of such conditions, or (b) terminate this
Agreement as provided below.

10.3         Termination. 
Either party may terminate this Agreement at any time for any reason,
without any further obligation to the non-terminating party; provided, however,
that: (a) no such termination will affect Placement Agent’s right to expense
reimbursement under Section 3.10 and (b) no such termination will affect
Placement Agent’s right to fees under Section 3.8 if the Company consummates a
private placement within twelve (12) months following such termination (if
any post Termination Date sales are made to investors located by the Placement
Agent prior to the Termination Date and made known to the Company in writing only
by Placement Agent’s efforts prior to the Termination Date).

11.           Notices.

11.1         Method and Location of Notices.  Any notice, reply or other communication
required or permitted by this Agreement, except as herein otherwise
specifically provided, shall be in writing and (i) if sent to the Placement
Agent, shall be mailed, delivered or telecopied and confirmed to Ed McClendon,
Terra Nova Financial, L.L.C., 100 S. Wacker, Suite 1550, Chicago, IL 60606 and
(ii) if sent to the Company, shall be mailed, delivered or telecopied and
confirmed to Bill Critchfield, Corgenix Medical Corporation, 11575 Main Street,
Suite 400,  Broomfield, CO 80020.  Any party may change its address for notice
by giving notice of its new address to the other parties in the manner
specified above.

11.2         Time of Notices. 
Notice shall be deemed to be given by the Placement Agent to the Company
or by the Company to the Placement Agent (i) if by personal delivery, on the
date of such delivery, (ii) if by telecopy, on the date of transmission, and
(iii) if mailed, three days after delivery to the mails, postage prepaid,
registered mail, return receipt requested, to the addresses provided in Section
12.1 hereof.

12.           Miscellaneous.

12.1         Confidentiality. 
The Placement Agent agrees and acknowledges that certain information
furnished by the Company pursuant to the Placement Agent’s requests may be of a
proprietary nature and that any information provided by the Company shall be
kept confidential and shall not be disclosed to any third party without the
prior approval of the Company except as may otherwise be required by law or
court order.

 10
 

12.2         Parties.  This
Agreement shall inure solely to the benefit of and shall be binding upon the
Placement Agent, the Company and their respective successors, legal
representatives and assigns, and no other person shall have or be construed to
have a legal or equitable right, remedy or claim under or in respect of or by
virtue of this Agreement or any provision herein contained.

12.3         Construction. 
This Agreement shall be construed in accordance with the laws of the
State of Illinois, without giving effect to the principles thereof relating to
the conflict of laws.

12.4         Descriptive Heading; Defined Terms.  The descriptive headings of the several
sections and paragraphs of this Agreement are inserted for convenience only and
do not constitute a part of this Agreement. 
Capitalized terms not otherwise defined in this Agreement shall have the
respective meanings set forth in the Marketing Materials.

12.5         Counterparts. 
This Agreement may be executed in one or more counterparts, and, if
executed in more than one counterpart, the executed counterparts shall together
constitute a single instrument.

12.6         Entire Agreement; Written Waivers.  This Agreement constitutes the entire
agreement of the parties and supersedes all prior written or oral and all
contemporaneous oral agreements, understandings and negotiations between the
parties with respect to the subject matter hereof.  Neither the Company nor the Placement Agent
has relied on any written or oral representations or inducements, other than
those which are set forth in this Agreement in executing and delivering this
Agreement.  No waiver, alteration or
modification of any of the provisions hereof shall be binding unless it is in
writing and signed by each of the parties hereto.

12.7         Severability. 
If any of the provisions of this Agreement are rendered or declared
illegal by reason of any existing or subsequently enacted legislation or by
decree of a court of last resort, the remaining provisions of the Agreement
shall remain in full force and effect.

12.8         Headings.  The
headings and captions of this Agreement are inserted for convenience of
reference only and shall not be deemed a part hereof or used in the
construction or interpretation hereof.

 11
 

If the foregoing correctly sets
forth the understanding between the Placement Agent and the Company, please so
indicate in the space provided below for that purpose, whereupon this letter
shall constitute a binding agreement among the parties.

	
  

  	
   

  	
   

  	
  Very truly yours,

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  	
  Name:

  	
   

  
	
   

  	
   

  	
   

  	
  Title:

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  AGREED AND ACCEPTED:

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Corgenix Medical Corporation

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  	
   

  
	
  Name:

  	
   

  	
   

  	
   

  	
   

  
	
  Title:

  	
   

  	
   

  	
   

  	
   

  

 

 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}]]